Next Article in Journal
Benefit of Early Ruxolitinib Initiation Regardless of Fibrosis Grade in Patients with Primary Myelofibrosis: A Post Hoc Analysis of the Single-Arm Phase 3b JUMP Study
Next Article in Special Issue
CBCT-Based Dose Monitoring and Adaptive Planning Triggers in Head and Neck PBS Proton Therapy
Previous Article in Journal
Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials
Previous Article in Special Issue
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design
 
 
Article

Article Versions Notes

Cancers 2023, 15(10), 2857; https://doi.org/10.3390/cancers15102857
Action Date Notes Link
article xml file uploaded 22 May 2023 06:24 CEST Original file -
article xml uploaded. 22 May 2023 06:24 CEST Update https://www.mdpi.com/2072-6694/15/10/2857/xml
article pdf uploaded. 22 May 2023 06:24 CEST Version of Record https://www.mdpi.com/2072-6694/15/10/2857/pdf
article html file updated 22 May 2023 06:25 CEST Original file https://www.mdpi.com/2072-6694/15/10/2857/html
Back to TopTop